Replies to post #13901 on Biostax Corp (BTAX)

[Ronin]

Don't bank on it. The 1000/1 R/S will take the share count down to 500K range. Usually, that means they want to be absorbed by another bigger firm who doesn't like their current A/S. OR, they're gonna dilute the piss out of it.

Either way, get in, get out. And let the games begin!!!!

Btw, chances are IMUN has news on the way. They got a few things cooking...

Good luck!

[Ronin]

Another theory on why no R/S will occur...

https://www.immunetherapeutics.com/2020/03/immune-therapeutics-inc-provides-updates-and-guidance-on-reverse-stock-split-and-name-change-2/

In this PR from March 9, 2020, the CEO, Mike says that the State of Florida has approved the R/S, and yet, that was weeks ago and FINRA has not approved it. We are thinking they don't like what IMUN is proposing and are going to deny them.

Or... they are just back-logged like so many other's affected the CV. But it is interesting that there's no peep out of FINRA so they may reject IMUN's request entirely! Not all R/S's are granted. Taking the A/S down to only 500K shares is suggesting "I got a secret..."

Immune Therapeutics originally submitted the reverse and name change request for a corporate action to FINRA and paid the applicable fees on November 27, 2019. Since then, the company has responded in a timely fashion to all of FINRA’s requests for further information, and we continue in our efforts to work diligently and cooperatively with FINRA to process the reverse and name change. FINRA requested a copy of the File-stamped articles of amendment from the state of incorporation approving the name change and reverse split which can be found by clicking on the following link.

http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=IMMUNETHERAPEUTICS%20P930000827363&aggregateId=domp-p93000082736-9253a8c1-cecc-409f-88a8-5c55c304b4fc&searchTerm=Immune%20Therapeutics&listNameOrder=IMMUNETHERAPEUTICS%20P930000827363

The Company approved the amended Articles of Incorporation and filed them with the State of Florida Division of Corporation, on February 20, 2020; the State of Florida accepted and approved the 1000-to-1 reverse split leaving 458,019 shares issued and outstanding. Please note that the Company has no control of the FINRA approval process and as such the timing of any decisions our not in the Company’s control.

[Ronin]

Our drug is ready to go...

https://www.immunetherapeutics.com/therapies-2/lodonal-international/

NSPX ran 3500% to .04 cents and they ain't got SQUAT on the market!!